Naturally Splendid Announces Senior UK Executive Appointed to Advisory Board

- March 1st, 2016

Naturally Splendid (TSXV:NSP) announced the appointment of Mr. Richard McGawley to its Corporate Advisory Board to assist the Company with identifying, developing and facilitating sales opportunities in a territory that includes Europe, the Middle East & Africa, as well as the Asian-Pacific Economic Cooperation regions.

Naturally Splendid (TSXV:NSP) announced the appointment of Mr. Richard McGawley to its Corporate Advisory Board to assist the Company with identifying, developing and facilitating sales opportunities in a territory that includes Europe, the Middle East & Africa, as well as the Asian-Pacific Economic Cooperation regions.
As quoted in the press release:

Mr. McGawley’s primary focus will be to assist management in the marketing and sales of the Company’s full range of plant based ingredients, including its proprietary HempOmega® and omega extraction and formulation technologies.
Mr. McGawley is a Director of ASL Recruitment (ASL), a recruitment company with operations located in the UK. ASL is an industry leader and their business operates across multiple sectors and geographical jurisdictions.  Mr. McGawley has over 15 years of experience in the Life Sciences arena across the EMEA and APEC regions and has a successful track record working with some of the largest global manufacturers, acting as not only an executive recruiter, but also as a business consultant providing valuable market insight. His primary business has allowed him to generate contacts and knowledge across all areas of the ingredient industry – R&D, Commercial, Operations and Regulatory. This contact network is extensive and includes Director and Board Level contacts in almost all of the major food, ingredient and flavours manufacturers.

Connect with Naturally Splendid (TSXV:NSP) to receive an Investor Presentation.

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply